全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用：99美元
投递稿件

查看量下载量

相关文章

更多...
PLOS ONE  2013 

Delayed Gadolinium-Enhanced MRI of Cartilage (dGEMRIC) Shows No Change in Cartilage Structural Composition after Viscosupplementation in Patients with Early-Stage Knee Osteoarthritis

DOI: 10.1371/journal.pone.0079785

Full-Text   Cite this paper   Add to My Lib

Abstract:

Introduction Viscosupplementation with hyaluronic acid (HA) of osteoarthritic (OA) knee joints has a well-established positive effect on clinical symptoms. This effect, however, is only temporary and the working mechanism of HA injections is not clear. It was suggested that HA might have disease modifying properties because of its beneficial effect on cartilage sulphated glycosaminoglycan (sGAG) content. Delayed gadolinium-enhanced MRI of cartilage (dGEMRIC) is a highly reproducible, non-invasive surrogate measure for sGAG content and hence composition of cartilage. The aim of this study was to assess whether improvement in cartilage structural composition is detected using dGEMRIC 14 weeks after 3 weekly injections with HA in patients with early-stage knee OA. Methods In 20 early-stage knee OA patients (KLG I-II), 3D dGEMRIC at 3T was acquired before and 14 weeks after 3 weekly injections with HA. To evaluate patient symptoms, the knee injury and osteoarthritis outcome score (KOOS) and a numeric rating scale (NRS) for pain were recorded. To evaluate cartilage composition, six cartilage regions in the knee were analyzed on dGEMRIC. Outcomes of dGEMRIC, KOOS and NRS before and after HA were compared using paired t-testing. Since we performed multiple t-tests, we applied a Bonferroni-Holm correction to determine statistical significance for these analyses. Results All KOOS subscales (‘pain’, ‘symptoms’, ‘daily activities’, ‘sports’ and ’quality of life’) and the NRS pain improved significantly 14 weeks after Viscosupplementation with HA. Outcomes of dGEMRIC did not change significantly after HA compared to baseline in any of the cartilage regions analyzed in the knee. Conclusions Our results confirm previous findings reported in the literature, showing persisting improvement in symptomatic outcome measures in early-stage knee OA patients 14 weeks after Viscosupplementation. Outcomes of dGEMRIC, however, did not change after Viscosupplementation, indicating no change in cartilage structural composition as an explanation for the improvement of clinical symptoms.

 References

[1]  Buckwalter JA, Saltzman C, Brown T (2004) The impact of osteoarthritis: implications for research. Clin Orthop Relat Res: S6-15. PubMed: 15480076.
[2]  Hermans J, Koopmanschap MA, Bierma-Zeinstra SM, van Linge JH, Verhaar JA et al. (2012) Productivity costs and medical costs among working patients with knee osteoarthritis. Arthritis Care Res (Hoboken) 64: 853-861. doi:10.1002/acr.21617. PubMed: 22262497.
[3]  Woolf AD, Pfleger B (2003) Burden of major musculoskeletal conditions. Bull World Health Organ 81: 646-656. PubMed: 14710506.
[4]  Hunter DJ (2011) Pharmacologic therapy for osteoarthritis--the era of disease modification. Nat Rev Rheumatol 7: 13-22. doi:10.1038/nrrheum.2010.178. PubMed: 21079644.
[5]  Balazs E, editor (1982) The physical properties of synovial fluid and the specific role of hyaluronic acid. Philadelphia: J B Lippincott Publishing House. pp. 61-74.
[6]  Divine JG, Zazulak BT, Hewett TE (2007) Viscosupplementation for knee osteoarthritis: a systematic review. Clin Orthop Relat Res 455: 113-122. doi:10.1097/BLO.0b013e31802f5421. PubMed: 17159579.
[7]  Bellamy N, Campbell J, Robinson V, Gee T, Bourne R et al. (2006) Viscosupplementation for the treatment of osteoarthritis of the knee. Cochrane Database Syst Rev CD: 005321. PubMed: 1662563515846754.
[8]  Goldberg VM, Buckwalter JA (2005) Hyaluronans in the treatment of osteoarthritis of the knee: evidence for disease-modifying activity. Osteoarthritis Cartilage 13: 216-224. doi:10.1016/j.joca.2004.11.010. PubMed: 15727888.
[9]  Moreland LW (2003) Intra-articular hyaluronan (hyaluronic acid) and hylans for the treatment of osteoarthritis: mechanisms of action. Arthritis Res Ther 5: 54-67. doi:10.1186/ar684. PubMed: 12718745.
[10]  Kawasaki K, Ochi M, Uchio Y, Adachi N, Matsusaki M (1999) Hyaluronic acid enhances proliferation and chondroitin sulfate synthesis in cultured chondrocytes embedded in collagen gels. J Cell Physiol 179: 142-148. doi:10.1002/(SICI)1097-4652(199905)179:2. PubMed: 10199553.
[11]  Frean SP, Abraham LA, Lees P (1999) In vitro stimulation of equine articular cartilage proteoglycan synthesis by hyaluronan and carprofen. Res Vet Sci 67: 183-190. doi:10.1053/rvsc.1999.0328. PubMed: 10502490.
[12]  St？ve J, Gerlach C, Huch K, Günther KP, Puhl W et al. (2002) Effects of hyaluronan on proteoglycan content of osteoarthritic chondrocytes in vitro. J Orthop Res 20: 551-555. doi:10.1016/S0736-0266(01)00141-3. PubMed: 12038630.
[13]  Kikuchi T, Yamada H, Fujikawa K (2001) Effects of high molecular weight hyaluronan on the distribution and movement of proteoglycan around chondrocytes cultured in alginate beads. Osteoarthritis Cartilage 9: 351-356. doi:10.1053/joca.2000.0395. PubMed: 11399099.
[14]  Buckwalter JA, Mankin HJ (1998) Articular cartilage: degeneration and osteoarthritis, repair, regeneration, and transplantation. Instr Course Lect 47: 487-504. PubMed: 9571450.
[15]  Grushko G, Schneiderman R, Maroudas A (1989) Some biochemical and biophysical parameters for the study of the pathogenesis of osteoarthritis: a comparison between the processes of ageing and degeneration in human hip cartilage. Connect Tissue Res 19: 149-176. doi:10.3109/03008208909043895. PubMed: 2805680.
[16]  Felson DT, Lawrence RC, Dieppe PA, Hirsch R, Helmick CG et al. (2000) Osteoarthritis: new insights. Part 1: the disease and its risk factors. Ann Intern Med 133: 635-646. doi:10.7326/0003-4819-133-8-200010170-00016. PubMed: 11033593.
[17]  Guermazi A, Roemer FW, Burstein D, Hayashi D (2011) Why radiography should no longer be considered a surrogate outcome measure for longitudinal assessment of cartilage in knee osteoarthritis. Arthritis Res Ther 13: 247. doi:10.1186/ar3488. PubMed: 22136179.
[18]  Kijowski R, Blankenbaker DG, Davis KW, Shinki K, Kaplan LD et al. (2009) Comparison of 1.5- and 3.0-T MR imaging for evaluating the articular cartilage of the knee joint. Radiology 250: 839-848. doi:10.1148/radiol.2503080822. PubMed: 19164121.
[19]  Zhang M, Min Z, Rana N, Liu H (2013) Accuracy of magnetic resonance imaging in grading knee chondral defects. Arthroscopy 29: 349-356. doi:10.1016/j.arthro.2012.04.138. PubMed: 22906758.
[20]  Crema MD, Roemer FW, Marra MD, Burstein D, Gold GE et al. (2011) Articular cartilage in the knee: current MR imaging techniques and applications in clinical practice and research. RadioGraphics 31: 37-61. doi:10.1148/rg.311105084. PubMed: 21257932.
[21]  Roemer FW, Crema MD, Trattnig S, Guermazi A (2011) Advances in imaging of osteoarthritis and cartilage. Radiology 260: 332-354. doi:10.1148/radiol.11101359. PubMed: 21778451.
[22]  Bashir A, Gray ML, Boutin RD, Burstein D (1997) Glycosaminoglycan in articular cartilage: in vivo assessment with delayed Gd(DTPA)(2-)-enhanced MR imaging. Radiology 205: 551-558. PubMed: 9356644.
[23]  Bashir A, Gray ML, Hartke J, Burstein D (1999) Nondestructive imaging of human cartilage glycosaminoglycan concentration by MRI. Magn Reson Med 41: 857-865. doi:10.1002/(SICI)1522-2594(199905)41:5. PubMed: 10332865.
[24]  van Tiel J, Bron EE, Tiderius CJ, Bos PK, Reijman M et al. (2013) Reproducibility of 3D delayed gadolinium enhanced MRI of cartilage (dGEMRIC) of the knee at 3.0 T in patients with early stage osteoarthritis. Eur Radiol 23: 496-504. doi:10.1007/s00330-012-2616-x. PubMed: 22886535.
[25]  McAlindon TE, Nuite M, Krishnan N, Ruthazer R, Price LL et al. (2011) Change in knee osteoarthritis cartilage detected by delayed gadolinium enhanced magnetic resonance imaging following treatment with collagen hydrolysate: a pilot randomized controlled trial. Osteoarthritis Cartilage 19: 399-405. doi:10.1016/j.joca.2011.01.001. PubMed: 21251991.
[26]  Prasad PV, Li W, Schnitzer T, Krishnan N, Burstein D (2012) Preliminary Evaluation of Potential Disease Modification by Hylan G-F 20 (Synvisc？) Using dGEMRIC. J Mol Imag Dynamic April, 2012.
[27]  Jensen MP, Miller L, Fisher LD (1998) Assessment of pain during medical procedures: a comparison of three scales. Clin J Pain 14: 343-349. doi:10.1097/00002508-199812000-00012. PubMed: 9874014.
[28]  Kellgren JH, Lawrence JS (1957) Radiological assessment of osteo-arthrosis. Ann Rheum Dis 16: 494-502. doi:10.1136/ard.16.4.494. PubMed: 13498604.
[29]  Roos EM, Toksvig-Larsen S (2003) Knee injury and Osteoarthritis Outcome Score (KOOS) - validation and comparison to the WOMAC in total knee replacement. Health Qual Life Outcomes 1: 17. doi:10.1186/1477-7525-1-17. PubMed: 12801417.
[30]  de Groot IB, Favejee MM, Reijman M, Verhaar JA, Terwee CB (2008) The Dutch version of the Knee Injury and Osteoarthritis Outcome Score: a validation study. Health Qual Life Outcomes 6: 16. doi:10.1186/1477-7525-6-16. PubMed: 18302729.
[31]  Hermans J, Bierma-Zeinstra SM, Bos PK, Verhaar JA, Reijman M (2011) The most accurate approach for intra-articular needle placement in the knee joint: a systematic review. Semin Arthritis Rheum 41: 106-115. doi:10.1016/j.semarthrit.2011.02.007. PubMed: 22036252.
[32]  Tiderius CJ, Olsson LE, de Verdier H, Leander P, Ekberg O et al. (2001) Gd-DTPA2)-enhanced MRI of femoral knee cartilage: a dose-response study in healthy volunteers. Magn Reson Med 46: 1067-1071. doi:10.1002/mrm.1300. PubMed: 11746570.
[33]  Tiderius C, Hori M, Williams A, Sharma L, Prasad PV et al. (2006) dGEMRIC as a function of BMI. Osteoarthritis Cartilage 14: 1091-1097. doi:10.1016/j.joca.2006.05.007. PubMed: 16782361.
[34]  Tiderius CJ, Olsson LE, Leander P, Ekberg O, Dahlberg L (2003) Delayed gadolinium-enhanced MRI of cartilage (dGEMRIC) in early knee osteoarthritis. Magn Reson Med 49: 488-492. doi:10.1002/mrm.10389. PubMed: 12594751.
[35]  Bron EE, van Tiel J, Smit H, Poot DH, Niessen WJ et al. (2013) Image registration improves human knee cartilage T1 mapping with delayed gadolinium-enhanced MRI of cartilage (dGEMRIC). Eur Radiol 23: 246-252. doi:10.1007/s00330-012-2590-3. PubMed: 22865226.
[36]  McKenzie CA, Williams A, Prasad PV, Burstein D (2006) Three-dimensional delayed gadolinium-enhanced MRI of cartilage (dGEMRIC) at 1.5T and 3.0T. J Magn Reson Imaging 24: 928-933. doi:10.1002/jmri.20689. PubMed: 16941612.
[37]  Tiderius CJ, Tj？rnstrand J, Akeson P, S？dersten K, Dahlberg L et al. (2004) Delayed gadolinium-enhanced MRI of cartilage (dGEMRIC): intra- and interobserver variability in standardized drawing of regions of interest. Acta Radiol 45: 628-634. doi:10.1080/02841850410008379. PubMed: 15587420.
[38]  Eckstein F, Ateshian G, Burgkart R, Burstein D, Cicuttini F et al. (2006) Proposal for a nomenclature for magnetic resonance imaging based measures of articular cartilage in osteoarthritis. Osteoarthritis Cartilage 14: 974-983. doi:10.1016/j.joca.2006.03.005. PubMed: 16730462.
[39]  Studler U, White LM, Andreisek G, Luu S, Cheng HL et al. (2010) Impact of motion on T1 mapping acquired with inversion recovery fast spin echo and rapid spoiled gradient recalled-echo pulse sequences for delayed gadolinium-enhanced MRI of cartilage (dGEMRIC) in volunteers. J Magn Reson Imaging 32: 394-398. doi:10.1002/jmri.22249. PubMed: 20677268.
[40]  Klein S, van der Heide UA, Lips IM, van Vulpen M, Staring M et al. (2008) Automatic segmentation of the prostate in 3D MR images by atlas matching using localized mutual information. Med Phys 35: 1407-1417. doi:10.1118/1.2842076. PubMed: 18491536.
[41]  Klein S, Staring M, Murphy K, Viergever MA, Pluim JP (2010) elastix: a toolbox for intensity-based medical image registration. IEEE Trans Med Imaging 29: 196-205. doi:10.1109/TMI.2009.2035616. PubMed: 19923044.
[42]  Cavassila S, Deval S, Huegen C, van Ormondt D, Graveron-Demilly D (2001) Cramér-Rao bounds: an evaluation tool for quantitation. NMR Biomed 14: 278-283. doi:10.1002/nbm.701. PubMed: 11410946.
[43]  Sijbers J, Den Dekker AJ, Raman E, Van Dyck D (1999) Parameter estimation from magnitude MR images. Int J Imaging Syst Technol 10: 109-114. doi:10.1002/(SICI)1098-1098(1999)10:2.
[44]  Rao CR (1946) Minimum variance and the estimation of several parameters 43. Cambridge University Press. pp. 280-283.
[45]  Hunter DJ, Guermazi A, Lo GH, Grainger AJ, Conaghan PG et al. (2011) Evolution of semi-quantitative whole joint assessment of knee OA: MOAKS (MRI Osteoarthritis Knee Score). Osteoarthritis Cartilage 19: 990-1002. doi:10.1016/j.joca.2011.05.004. PubMed: 21645627.
[46]  Holm S (1979) A simple sequentially rejective multiple test procedure. Scand J Stat 6: 65-70.
[47]  Chan AO, Jim MH, Lam KF, Morris JS, Siu DC et al. (2007) Prevalence of colorectal neoplasm among patients with newly diagnosed coronary artery disease. JAMA 298: 1412-1419. doi:10.1001/jama.298.12.1412. PubMed: 17895457.
[48]  Kimelman T, Vu A, Storey P, McKenzie C, Burstein D et al. (2006) Three-dimensional T1 mapping for dGEMRIC at 3.0 T using the Look Locker method. Invest Radiol 41: 198-203. doi:10.1097/01.rli.0000195842.49255.ea. PubMed: 16428993.
[49]  Williams A, Mikulis B, Krishnan N, Gray M, McKenzie C et al. (2007) Suitability of T(1Gd) as the dGEMRIC index at 1.5T and 3.0T. Magn Reson Med 58: 830-834. doi:10.1002/mrm.21376. PubMed: 17899599.
[50]  Zhang W, Nuki G, Moskowitz RW, Abramson S, Altman RD et al. (2010) OARSI recommendations for the management of hip and knee osteoarthritis: part III: Changes in evidence following systematic cumulative update of research published through January 2009. Osteoarthritis Cartilage 18: 476-499. doi:10.1016/j.joca.2010.01.013. PubMed: 20170770.
[51]  Ghosh P, Holbert C, Read R, Armstrong S (1995) Hyaluronic acid (hyaluronan) in experimental osteoarthritis. J Rheumatol Suppl 43: 155-157. PubMed: 7752123.
[52]  Larsen NE, Lombard KM, Parent EG, Balazs EA (1992) Effect of hylan on cartilage and chondrocyte cultures. J Orthop Res 10: 23-32. doi:10.1002/jor.1100100104. PubMed: 1727935.
[53]  Yoshioka M, Shimizu C, Harwood FL, Coutts RD, Amiel D (1997) The effects of hyaluronan during the development of osteoarthritis. Osteoarthritis Cartilage 5: 251-260. doi:10.1016/S1063-4584(97)80021-0. PubMed: 9404470.
[54]  Huang GS, Lee HS, Chou MC, Shih YY, Tsai PH et al. (2010) Quantitative MR T2 measurement of articular cartilage to assess the treatment effect of intra-articular hyaluronic acid injection on experimental osteoarthritis induced by ACLX. Osteoarthritis Cartilage 18: 54-60. doi:10.1016/S1063-4584(10)60132-X. PubMed: 19761884.
[55]  Wang Y, Hall S, Hanna F, Wluka AE, Grant G et al. (2011) Effects of Hylan G-F 20 supplementation on cartilage preservation detected by magnetic resonance imaging in osteoarthritis of the knee: a two-year single-blind clinical trial. BMC Musculoskelet Disord 12: 195. doi:10.1186/1471-2474-12-195. PubMed: 21861935.
[56]  Salo EN, Nissi MJ, Kulmala KA, Tiitu V, T？yr？s J et al. (2012) Diffusion of Gd-DTPA2？ into articular cartilage. Osteoarthritis Cartilage 20: 117-126. doi:10.1016/j.joca.2012.02.143. PubMed: 22179030.
[57]  von den Hoff JW, van Kampen GP, van de Stadt RJ, van der Korst JK (1993) Kinetics of proteoglycan turnover in bovine articular cartilage explants. Matrix 13: 195-201. doi:10.1016/S0934-8832(11)80003-X. PubMed: 8326910.
[58]  van Kampen GP, van de Stadt RJ, van der Korst JK (1991) 'Resident' proteoglycans in mature articular cartilage. Trans Orthop Res Soc 16.
[59]  Maroudas A (1975) Glycosaminoglycan turn-over in articular cartilage. Philos Trans R Soc Lond B Biol Sci 271: 293-313. doi:10.1098/rstb.1975.0054. PubMed: 239424.
[60]  Guidolin DD, Ronchetti IP, Lini E, Guerra D, Frizziero L (2001) Morphological analysis of articular cartilage biopsies from a randomized, clinical study comparing the effects of 500-730 kDa sodium hyaluronate (Hyalgan) and methylprednisolone acetate on primary osteoarthritis of the knee. Osteoarthritis Cartilage 9: 371-381. doi:10.1053/joca.2000.0398. PubMed: 11399102.
[61]  Pasquali Ronchetti I, Guerra D, Taparelli F, Boraldi F, Bergamini G et al. (2001) Morphological analysis of knee synovial membrane biopsies from a randomized controlled clinical study comparing the effects of sodium hyaluronate (Hyalgan) and methylprednisolone acetate (Depomedrol) in osteoarthritis. Rheumatology (Oxford) 40: 158-169. doi:10.1093/rheumatology/40.2.158. PubMed: 11257152.
[62]  Frizziero L, Govoni E, Bacchini P (1998) Intra-articular hyaluronic acid in the treatment of osteoarthritis of the knee: clinical and morphological study. Clin Exp Rheumatol 16: 441-449. PubMed: 9706425.
[63]  Loeser RF, Goldring SR, Scanzello CR, Goldring MB (2012) Osteoarthritis: a disease of the joint as an organ. Arthritis Rheum 64: 1697-1707. doi:10.1002/art.34453. PubMed: 22392533.
[64]  Scanzello CR, Goldring SR (2012) The role of synovitis in osteoarthritis pathogenesis. Bone 51: 249-257. doi:10.1016/j.bone.2012.02.012. PubMed: 22387238.
[65]  Sofat N, Ejindu V, Kiely P (2011) What makes osteoarthritis painful? The evidence for local and central pain processing. Rheumatology (Oxf) 50: 2157-2165. doi:10.1093/rheumatology/ker283.

Full-Text

Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133